Agreement between different eGFR equations in diagnosing contrast-induced acute kidney injury in patients undergoing elective coronary or peripheral angiography

1 van der Molen AJ, Reimer P, Dekkers IA, Bongartz G, Bellin MF, Bertolotto M, et al. Post-contrast acute kidney injury - Part 1: Definition, clinical features, incidence, role of contrast medium and risk factors: Recommendations for updated ESUR Contrast Medium Safety Committee guidelines. Eur Radiol. 2018;28:2845-55. DOI: 10.1007/s00330-017-5246-5 Search in Google Scholar

2 Dong M, Jiao Z, Liu T, Guo F, Li G. Effect of administration route on the renal safety of contrast agents: a meta-analysis of randomized controlled trials. J Nephrol. 2012;25:290-301. DOI: 10.5301/jn.5000067 Search in Google Scholar

3 Mouton R, Holder K. Laboratory tests of renal function. Anaesthesia & Intensive Care Medicine 2006;7:240-3. DOI: 10.1053/j.mpaic.2006.04.003 Search in Google Scholar

4 Hošková L, Franekova J, Málek I, Kautzner J, Szárszoi O, Jabor A, et al. Comparison of Cystatin C and NGAL in Early Diagnosis of Acute Kidney Injury After Heart Transplantation. Ann Transplant. 2016;21:329-245. DOI: 10.12659/AOT.896700 Search in Google Scholar

5 Liu Z, Shang A, Chen Z, Yin L, Qi H. Neutrophil gelatinase-associated lipocalin as an early predictor of contrast-induced nephropathy following endovascular therapy for arteriosclerosis obliterans. Medicine. 2020;99:e21386. DOI: 10.1097/MD.0000000000021386 Search in Google Scholar

6 Zhang W-F, Zhang T, Ding D, Sun S-Q, Wang X-L, Chu S-C, et al. Use of Both Serum Cystatin C and Creatinine as Diagnostic Criteria for Contrast-Induced Acute Kidney Injury and Its Clinical Implications. J Am Heart Assoc. 2017;6:e004747. DOI: 10.1161/JAHA.116.004747 Search in Google Scholar

7 Endre ZH, Walker RJ. Chapter Eleven - Biomarkers of Cardiovascular Risk in Chronic Kidney Disease. In: Edelstein CL, editor. Biomarkers of Kidney Disease (Second Edition), Academic Press. 2017, p. 485-511. DOI: 10.1016/B978-0-12-803014-1.00011-X Search in Google Scholar

8 Breglia A, Godi I, Virzì GM, Guglielmetti G, Iannucci G, De Cal M, et al. Subclinical Contrast-Induced Acute Kidney Injury in Patients Undergoing Cerebral Computed Tomography. Cardiorenal Med. 2020;10:125-36. DOI: 10.1159/000505422 Search in Google Scholar

9 Petrova I, Alexandrov A, Vladimirov G, Mateev H, Bogov I, Paskaleva I, et al. NGAL as Biomarker of Clinical and Subclinical Damage of Kidney Function after Coronary Angiography. Diagnostics (Basel). 2023;13:1180. DOI: 10.3390/diagnostics13061180 Search in Google Scholar

10 Maioli M, Toso A, Leoncini M, Gallopin M, Musilli N, Bellandi F. Persistent Renal Damage After Contrast-Induced Acute Kidney Injury. Circulation. 2012;125:3099-107. DOI: 10.1161/CIRCULATIONAHA.111.085290 Search in Google Scholar

11 Gruberg L, Mintz GS, Mehran R, Gangas G, Lansky AJ, Kent KM, et al. The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol. 2000;36:1542-8. DOI: 10.1016/S0735-1097(00)00917-7 Search in Google Scholar

12 McCullough PA, Wolyn R, Rocher LL, Levin RN, O’Neill WW. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med. 1997;103:368-75. DOI: 10.1016/S0002-9343(97)00150-2 Search in Google Scholar

13 Malavasi VL, Valenti AC, Ruggerini S, Manicardi M, Orlandi C, Sgreccia D, et al. Kidney Function According to Different Equations in Patients Admitted to a Cardiology Unit and Impact on Outcome. J Clin Med. 2022;11:891. DOI: 10.3390/jcm11030891 Search in Google Scholar

14 Shacham Y, Leshem-Rubinow E, Steinvil A, Assa E Ben, Keren G, Roth A, et al. Renal impairment according to acute kidney injury network criteria among ST elevation myocardial infarction patients undergoing primary percutaneous intervention: a retrospective observational study. Clin Res Cardiol. 2014;103:525-32. DOI: 10.1007/s00392-014-0680-8 Search in Google Scholar

15 Murray PT, Mehta RL, Shaw A, Ronco C, Endre Z, Kellum JA, et al. Potential use of biomarkers in acute kidney injury: report and summary of recommendations from the 10th Acute Dialysis Quality Initiative consensus conference. Kidney Int. 2014;85:513-21. DOI: 10.1038/ki.2013.374 Search in Google Scholar

16 Lupu L, Abukatash H, Banai A, Rozenfeld K-L, Lewit D, Merdler I, et al. Relation of Baseline Neutrophil Gelatinase-Associated Lipocalin (NGAL) Levels and Contrast-Induced Nephropathy following Percutaneous Coronary Intervention among Chronic Kidney Disease Patients. J Clin Med. 2021;10:5403. DOI: 10.3390/jcm10225403 Search in Google Scholar

17 Ogedegbe HO. Renal Function Tests: A Clinical Laboratory Perspective. Lab Med. 2007;38:295-304. DOI: 10.1309/RWG5DY7RG1CYBUR7 Search in Google Scholar

18 Briguori C, Visconti G, Rivera N V, Focaccio A, Golia B, Giannone R, et al. Cystatin C and Contrast-Induced Acute Kidney Injury. Circulation. 2010;121:2117-22. DOI: 10.1161/CIRCULATIONAHA.109.919639 Search in Google Scholar

19 Wacker-Gußmann A, Bühren K, Schultheiss C, Braun SL, Page S, Saugel B, et al. Prediction of Contrast-Induced Nephropathy in Patients With Serum Creatinine Levels in the Upper Normal Range by Cystatin C: A Prospective Study in 374 Patients. AJR Am J Roentgenol. 2014;202:452-8. DOI: 10.2214/AJR.13.10688 Search in Google Scholar